Elixir Pharmaceuticals Obtains $12,000,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=01059ba1-bae0-45f6-a9f6-045a50e4b3e5&Preview=1 -
Date
5/19/2009 -
Company Name
Elixir Pharmaceuticals -
Mailing Address
12 Emily Street Cambridge, MA 02139 -
Company Description
Elixir Pharmaceuticals is a genomics-based drug discovery company developing a new category of pharmaceuticals that treat and/or prevent the broad spectrum of diseases that accompany aging. -
Website
http://www.elixirpharm.com -
Transaction Type
Venture Equity -
Transaction Amount
$12,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
MPM Capital -
Venture Investor
Novartis -
Venture Investor
ARCH Venture Partners -
Venture Investor
Oxford Bioscience Partners -
Venture Investor
Physic Ventures -
Venture Investor
Undisclosed
